Reserve Bank of India has notified that Foreign Institutional Investors (FIIs)/Foreign Portfolios Investors (FPIs) can now invest up to 49% of the paid up capital of Natco Pharma under the Portfolio Investment Scheme (PIS).
The company has already passed resolutions at its Board of Directors’ level and a special resolution by general body agreeing for enhancing the FII/FPI investment limit under Portfolio Investment Scheme from 31.50% to 49% of the paid up capital of the company.